Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias

PACE - Pacing and Clinical Electrophysiology

Volumn 26, Issue 1 II, 2003, Pages 461-465

  Boriani, Giuseppe ^a   Wollmann, Christian ^b   Biffi, Mauro ^a   Kühl, Martin ^c   Schuchert, Andreas ^d   Sperzel, Johannes ^g   Stiller, Sascha ^e   Gasparini, Gianni ^f   Böcker, Dirk ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Guidant   (United States)

^d UNIVERSITY OF HAMBURG   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f Mestre Hospital   (Italy)

^g NONE

Author keywords

Atrial fibrillation; Atrial tachyarrhythmia; Cardioversion; Defibrillation; Detection time; Implantable cardioverter defibrillator

Indexed keywords

ADULT; AGED; BIOMEDICAL TECHNOLOGY ASSESSMENT; CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RELIABILITY;

EID: 0347926095     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00072.x     Document Type: Conference Paper

References (11)

1. Boriani G, Biffi M, Martignani C, et al. Current clinical perspectives on implantable devices for atrial fibrillation. Curr Opin Cardiol 2002; 17:82-89.
2. Jung W, Wolpert C, Esmailzadeh B, et al. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000; 4(Suppl. 1):185-195.
3. Gold MR, Sulke N, Schwartzman DS, et al. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001; 12:1247-1253.
4. Gronefeld DC, Mauss O, Li Yg, et al. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: Results from a prospective study. J Cardiovasc Electrophysiol 2000; 11:1208-1214.
5. Boriani G, Biffi M, Padeletti M, et al. Effects of consistent atrial pacing and atrial rate stabilization - two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady-tachy syndrome. Eur Heart J 2001; 3(Suppl. P):P7-P15.
6. Disertori M, Padeletti L, Santini M, et al. Antitachycardia pacing therapies to terminate atrial tachycardias: The AT500 Italian Registry. Eur Heart J 2001; 3(Suppl. P): P16-P24.
7. Adler SW, Wolpert C, Warman EN, et al. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001; 104:887-892.
8. Benser ME, Walcott GP, Killingsworth CR, et al. Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator. J Cardiovasc Electrophysiol 2001; 12:957-964.
9. Cooklin M, Olsovsky MR, Brockman RG, et al. Atrial defibrillation with a transvenous lead. J Am Coll Cardiol 1999; 34:358-362.
10. Israel CW, Ehrlich JR, Gronefeld G, et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation. J Am Coll Cardiol 2001; 38:355-363.
11. Steunhaus DM, Cardinal DS, Mongeon L, et al. Internal defibrillation: Pain perception of low energy shocks. PACE 2002; 25:1090-1093.